Bright Minds Biosciences Inc.
DRUG | NASDAQ
$61.44
+$1.98 (+3.33%)
Sep 22, 2026, 12:23 PM ET · Market open
TTM Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 40.1K | 20.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -40.1K | -20.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -39.87M | -31.43M | -19.22M | -13.94M | -9.06M | -5.53M | -2.74M | -2.81M | -3.57M | -5.24M | -6.73M | -7.33M | -8.79M | -10.03M | -12.45M | -14.98M | -14.93M | -15.92M | -12.99M | -8.79M | -6.22M | -2.61M | -1.06M |
Interest Income | 6.95M | 4.56M | 2.33M | 1.52M | 995.94K | 534.69K | 25.31K | 20.99K | 14.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -24.75M | -27.53M | -19.84M | -12.23M | -8.92M | -3.44M | -1.07M | -2.8M | -3.56M | -5.24M | -6.72M | -7.37M | -8.81M | -10.01M | -12.44M | -14.96M | -14.87M | -15.75M | -12.84M | -8.66M | -6.2M | -2.7M | -1.13M |
Net Income | -24.75M | -27.53M | -19.84M | -12.23M | -8.92M | -3.44M | -1.07M | -2.8M | -3.56M | -5.24M | -6.72M | -7.37M | -8.81M | -10.01M | -12.44M | -14.96M | -14.87M | -15.75M | -12.84M | -8.66M | -6.2M | -2.7M | -1.13M |
Selling & General & Admin | 6.29M | 4.67M | 3.11M | 2.57M | 2.16M | 1.89M | 1.58M | 1.44M | 1.54M | 1.6M | 1.8M | 2.2M | 2.17M | 2.39M | 2.47M | 2.55M | 2.87M | 3.15M | 2.96M | 2.29M | 1.64M | 772.84K | 325.12K |
Research & Development | 33.21M | 26.4M | 15.7M | 11.08M | 6.72M | 3.46M | 999.85K | 1.18M | 1.86M | 3.47M | 4.77M | 5M | 6.45M | 7.45M | 9.8M | 12.18M | 11.85M | 12.5M | 9.81M | 6.31M | 4.4M | 1.72M | 676.16K |
Other Expenses | 332.77K | 345.29K | 403.51K | 287.65K | 187.96K | 186.8K | 163.25K | 197.19K | 172.94K | 161.58K | 165.38K | 134.01K | 173.13K | 181.14K | 181.56K | 243.08K | 217.46K | 261.77K | 230.3K | 181.74K | 173.7K | 121.37K | 59.33K |
Operating Expenses | 39.83M | 31.41M | 19.22M | 13.94M | 9.06M | 5.53M | 2.74M | 2.81M | 3.57M | 5.24M | 6.73M | 7.33M | 8.79M | 10.03M | 12.45M | 14.98M | 14.93M | 15.92M | 12.99M | 8.79M | 6.22M | 2.61M | 1.06M |
Interest Expense | 9.77K | 5.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 353.68K | 466.35K | 450.56K | 429.66K | 282.22K | 169.54K | 83.2K | 41.6K | 73.2K | 110.3K | 114.95K | 119.42K | 157.41K | 200.43K | 372.65K | 551.86K | 623.73K | 1.02M | 1.06M | 852.15K | 715.31K | 241.78K | 22.9K |
Cost & Expenses | 39.87M | 31.43M | 19.22M | 13.94M | 9.06M | 5.53M | 2.74M | 2.81M | 3.57M | 5.24M | 6.73M | 7.33M | 8.79M | 10.03M | 12.45M | 14.98M | 14.93M | 15.92M | 12.99M | 8.79M | 6.22M | 2.61M | 1.06M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 9.83M | 9.59M | 7.76M | 7.17M | 7.08M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 3.84M | 3.77M | 3.77M | 3.79M | 3.59M | 2.98M | 2.37M | 2.37M | 2.37M | 2.37M | 2.26M | 1.39M | 1.16M |
Shares Outstanding (Diluted) | 9.83M | 9.59M | 7.76M | 7.17M | 7.08M | 4.65M | 4.65M | 4.65M | 4.65M | 4.46M | 3.84M | 3.77M | 3.77M | 3.79M | 3.59M | 2.98M | 2.37M | 2.37M | 2.37M | 2.37M | 2.26M | 1.39M | 1.16M |
EPS (Basic) | -2.76 | -3.24 | -2.78 | -1.80 | -1.56 | -0.77 | -0.24 | -0.69 | -0.93 | -1.37 | -1.80 | -2.04 | -2.61 | -3.34 | -4.68 | -6.05 | -6.28 | -6.72 | -5.96 | -4.56 | -3.68 | -2.15 | -1.02 |
EPS (Diluted) | -2.76 | -3.24 | -2.75 | -1.77 | -1.53 | -0.74 | -0.24 | -0.69 | -0.93 | -1.37 | -1.80 | -2.04 | -2.61 | -3.34 | -4.68 | -6.05 | -6.28 | -6.72 | -5.96 | -4.56 | -3.68 | -2.15 | -1.02 |
EBITDA | -33.94M | -27.45M | -19.77M | -12.15M | -8.84M | -3.36M | -991.29K | -2.73M | -1.95M | -2.23M | -3.7M | -4.35M | -7.34M | -9.97M | -12.42M | -14.96M | -14.87M | -15.75M | -12.81M | -8.57M | -6.1M | -2.61M | -1.06M |
EBIT | -34.01M | -27.52M | -19.84M | -12.23M | -8.92M | -3.44M | -1.07M | -2.8M | -3.56M | -5.24M | -6.72M | -7.37M | -8.81M | -10.01M | -12.44M | -14.96M | -14.87M | -15.75M | -12.81M | -8.57M | -6.1M | -2.61M | -1.06M |
Depreciation & Amortization | 76.9K | 72.77K | 75.12K | 76.87K | 78.88K | 81.15K | 76.78K | 73.36K | 1.6M | 3.02M | 3.02M | 3.02M | 1.47M | 2.7M | 7.06M | 11.76M | 14.71M | 15.65M | 12.76M | 8.62M | 5.67M | 2.07M | 580.55K |
Add to Watchlist
Select watchlists to add or remove DRUG